Exogen Biotechnology, Inc.

Exogen Biotechnology is a Berkeley-based healthcare startup dedicated to quantifying DNA damage and assessing cellular DNA repair capacities. Over 40% of the US population will be diagnosed with cancer and doctors desperately need a way to identify at risk cancer patients and stratify cancer patients for various treatment options. Exogen Bio has developed a technology capable of identifying novel DNA prognostic markers that allows clinicians to better prevent and treat cancer.

CAT Scientific

CAT Scientific distributes a variety of advanced laboratory equipment for pharmaceutical, chemical, and good industry laboratories. High quality equipment including homogenizer drives, magnetic hotplate stirrers, overhead stirrers, and liquid handling contiburettes. More recently, CAT Scientific has been working with many startups in the field of cannabis extracts, offering assistance in the challenges of obtaining stability when decarboxylating cannabis extracts, working with acidic cannabinoids and emulsifying extracts. The more advanced laboratory equipment is critical to creating stability in the products created from these elements.

Deepcell, Inc.

Deepcell aims to provide detailed genetic health information through ordinary blood sampling. DeepCell's mission is to eliminate the need for invasive diagnostic tests.

BioVendor, LLC

Established in 2004 as a daughter company of the Czech company BioVendor – Laboratorni medicina a.s. (Est. 1992), as a supplier of immunoassays, antibodies, recombinant proteins, and endotoxin removal and detection products. BioVendor's R&D efforts are aimed at rapidly growing fields of interest within the international research and diagnostic community, such as Obesity/Metabolic syndrome/Diabetes, Cardiovascular physiology, Renal disease and injury, Bone metabolism/Os­teoporosis, Infection/Inflam­mation, Oncology/Tumor markers and more. BioVendor products are the result of long-term R&D activities, based on the capability of our research professionals to set new targets and to develop and manufacture new products, some of which being unique in the world, or being the first commercial assays, recombinant proteins or antibodies available on the market. BioVendor also distributes Hyglos GMBH endotoxin removal products and detection assays which rely on recombinant technology instead of horseshoe crab blood. These products are highly specific, have low lot-to-lot variability, and enable users to measure endotoxin in more complex samples than is allowable from other commercial assays. Oure parent company, BioVendor – Laboratorni medicina a.s., is EN ISO 13485:2000, ISO 9001:2000 and ISO 14001 certified, assuring that the development and manufacturing processes of all our products meet all quality control as well as environmental management criteria required.

Biopharm Inc